Find policies, billing codes, payers, states, and providers
Loading...
Find policies, billing codes, payers, states, and providers
CPT 17000: Destruction of First or Only Premalignant Lesion
CPT-17003-DESTRUCTION-PREMALIGNANT-LESIONS-ADD-ON-2-14-LESIONSCPT 17003: Destruction of Premalignant Lesion (Add‑On, Lesions 2–14)
CPT-17004-DESTRUCTION-15-OR-MORE-PREMALIGNANT-LESIONSCPT 17004: Destruction of 15+ Premalignant Lesions
CPT-17106-LASER-DESTRUCTION-CUTANEOUS-VASCULAR-LESION-LESS-THAN-10CM2CPT 17106: Cutaneous Vascular Lesion Destruction (<10 cm2)
CPT-17107-CUTANEOUS-VASCULAR-LESION-DESTRUCTION-10-50-CM2CPT 17107: Cutaneous Vascular Lesion Destruction 10.0–50.0 cm2
CPT-17108-CUTANEOUS-VASCULAR-DESTRUCTION-GREATER-THAN-50CM2CPT 17108: Cutaneous Vascular Lesion Destruction >50 cm2
CPT-17110-DESTRUCTION-BENIGN-CUTANEOUS-LESIONS-1-TO-14CPT 17110: Destruction of 1–14 Benign Skin Lesions
CPT-17111-DESTRUCTION-BENIGN-SKIN-LESIONS-15-OR-MORECPT 17111: Destruction of 15 or More Benign Skin Lesions
CPT-17250-CHEMICAL-CAUTERIZATION-GRANULATION-TISSUECPT 17250: Chemical Cauterization of Granulation Tissue
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.